Tag Archives: FEAM

EU Directive ‘cannot be implemented in isolation’ Brussels roundtable agrees

At a roundtable discussion on the use of animals in scientific research there is overwhelming agreement that Europe has appropriate and detailed legislation regulating the use of animals in scientific research, that adapts to and encourages scientific progress.

Conclusions also show that successful implementation of the Directive is a shared responsibility. The round table identified opportunities to join forces and work together, as the Directive 2010/63/EU cannot be successfully implemented by organisations or individuals working in isolation.

At the meeting in Brussels, representatives from the diverse sectors within the biomedical community (academia, industry, research organisations, medical charities, etc.) and policy-makers discuss the recommendations of the European Commission review report of the Directive 2010/63/EU on the protection of animals used for scientific purposes.

The objective of the roundtable was to  inform policy discussion in EU institutions and to identify recommendations for the users’ community on this basis. Topics under discussion were: the implementation of the Directive; improving openness and transparency; ideas for further areas to be tackled. Continue reading

Supporting excellent biomedical science in Europe

The first FEAM European Biomedical Policy Forum annual lecture took place in Brussels, in March, dedicated to the topic Biomedical and health research: developing a vision for Europe.

The Forum is an initiative from the Federation of European Academies of Medicine (FEAM) and aims to bring together representatives from academia, research charities, industry, European and national trade associations and professional bodies, regulators, public health bodies, and patient and consumers groups. Among the topics discussed were: thematic priorities for future research; linkage with the UN Sustainable Development Goals (SDGs); research missions; current gaps in support; and how to improve coordination and consolidation of research programmes across Europe.

This  is  an  important  time  for  European  health  policy  and  for  sustaining  biomedical  research  and innovation. The forthcoming EU Framework Programme for Research and Innovation, FP9, provides a critical opportunity for stakeholders across the biomedical and health sectors to discuss their research vision and priorities for Europe, linkage with global goals, and defining approaches to closing gaps in support and to promoting coordination of effort. Continue reading